Silent cerebral infarcts (SCI), which are linked to small-vessel disease, are more frequent than obvious strokes
According to NICE guidelines (TA875), semaglutide is approved for weight management in the UK, specifically for individuals with a BMI over 30 with weight-related conditions, or over 35 without such conditions
Drug products, such as Semaglutide Injection and Tirzepatide Injection, did not include necessary statements on the labels
The administration of a neutralizing anti-NGF antibody abrogated signaling through the NGF/TrkA/Akt pathway in the liver in our previous study (Figure 4), according to our hypothesis
however, their pharmacodynamic effects and pharmacological mechanisms in non-alcoholic steatohepatitis (NASH) remain unclear